New Zealand Reaffirms Ban On "Methods" Patents
In a lawsuit that reaffirms a key principle in New Zealand's patent policy, Pfizer has lost an appeal seeking a reversal of a High Court decision that the company could not...To view the full article, register now.
Already a subscriber? Click here to view full article